Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 8, 2024Effective PharmacotherapyOpen Access

Modern Possibilities of Hormone Targeted Therapy in Metastatic Receptor-Positive HER2-Negative Breast Сancer. A Clinical Case

View Full Paper
Ask AI
Bookmark
Share

Authors

ASA.S. ShatokhinaМЛМ. Г. ЛеоновJSJulia Shevchenko

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shatokhina et al. (2024) studied this question.

synapsesocial.com/papers/68e5d23bb6db643587567e38https://doi.org/10.33978/2307-3586-2024-20-22-14-16
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 Inhibitors2026 · 2 citations
  2. 2Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer2026 · 3 citations
  3. 3Navigating the post-CDK4/6 inhibitor era: a clinical algorithm for hormone receptor-positive metastatic breast cancer2026
  4. 4Updates to the Management of HR-Positive, HER2-Negative Breast Cancer2024
  5. 5The Evolution of Targeted Therapies in Early Hormone Receptor-Positive, HER2-Negative Breast Cancer2026